Barrett's esophagus (BE) is a common condition associated with chronic gastroesophageal
reflux disease. BE is the only known precursor to esophageal adenocarcinoma, a highly …

Barrett's esophagus (BE) is a change in the distal esophageal mucosal lining, whereby
metaplastic columnar epithelium replaces squamous epithelium of the esophagus. This …

EET is now standard of care and endorsed by societal guidelines for the treatment of
Barrett's oesophagus related neoplasia. Future studies should focus on risk stratification …

METHODS: Patients with nondysplastic BE had endoscopy with systematic esophageal
photographic mapping, biopsy, and volumetric laser endomicroscopy performed before and …

Barrett's esophagus (BE) is a condition resulting from an acquired metaplastic epithelial
change in the esophagus in response to gastroesophageal reflux. BE is the only known …

Over the past few decades, the rates of esophageal adenocarcinoma (EAC) in the USA
continue to increase, particularly in adults≥ 65 years old (Fig. 1)[1]. Barrett's esophagus …

Background and Aims After endoscopic eradication of Barrett's esophagus (BE), recurrence
of intestinal metaplasia at the gastroesophageal junction (GEJIM) is common. The clinical …

Barrett's esophagus is a metaplastic change of esophageal mucosa, which can be
characterized by its salmon-colored lining and the presence of columnar epithelium with …

Endoscopic therapy is currently the standard of care for the treatment of high-grade
dysplasia (HGD) or intramucosal adenocarcinoma (IMC) in patients with Barrett's esophagus …

Purpose of review Barrett's esophagus (BE) is an acquired condition caused by chronic
gastroesophageal reflux disease which can progress to esophageal adenocarcinoma …